| 21.05.2025 12:41 | FARN | IN BRIEF: Faron Pharmaceuticals appoints new chief business officer | Alliance |
| 14.03.2025 14:09 | FARN, BOR, BRS | UK shareholder meetings calendar - next 7 days | Alliance |
| 03.03.2025 12:05 | FARN | FDA Grants Orphan Drug Designation | RNS |
| 28.02.2025 12:00 | FARN | Notice of Annual General Meeting | RNS |
| 27.02.2025 07:30 | FARN | Positive EMA Opinion on Orphan Drug Designation | RNS |
| 27.02.2025 07:15 | FARN | Annual Report 2024 published | RNS |
| 27.02.2025 07:00 | FARN | Financial Statement 1 January to 31 December 2024 | RNS |
| 20.02.2025 14:16 | WPP, WKS, SHC | UK earnings, trading statements calendar - next 7 days | Alliance |
| 19.02.2025 10:00 | FARN | Notice of Financial Statement and Annual Report | RNS |
| 14.02.2025 12:00 | FARN | Holding(s) in Company | RNS |
| 11.02.2025 07:30 | FARN | Change of Broker | RNS |
| 06.02.2025 15:00 | FARN | Holding(s) in Company | RNS |
| 06.02.2025 11:41 | FARN | Faron Pharmaceuticals raises EUR12 million from oversubscribed placing | Alliance |
| 06.02.2025 07:00 | FARN | Results of Oversubscribed Placing | RNS |
| 05.02.2025 16:30 | FARN | Proposed Issue and Placing | RNS |
| 31.01.2025 07:00 | FARN | Final Patient Identified for BEXMAB Phase II Study | Reach |
| 10.12.2024 14:31 | FARN | IN BRIEF: Faron Pharmaceuticals shares up as presents data on Bexmab | Alliance |
| 02.12.2024 08:00 | FARN | Interactions with UK Regulatory Authorities | Reach |
| 27.11.2024 11:29 | FARN | Faron announces promising findings from blood cancer drug trial | Alliance |
| 27.11.2024 07:00 | FARN | Positive Phase 2 Interim Results from BEXMAB Trial | RNS |
| 11.11.2024 07:00 | FARN | Targeting Soluble Clever-1 for Autoimmune Diseases | Reach |
| 05.11.2024 07:00 | FARN | Shareholders’ Nomination Board | RNS |
| 22.10.2024 07:00 | FARN | Faron’s Capital Markets Day 2024 | RNS |
| 07.10.2024 07:00 | FARN | Faron announces Capital Markets Day | Reach |
| 27.08.2024 11:08 | FARN | Faron Pharma shares surge as US FDA grants fast track designation | Alliance |
| 27.08.2024 07:00 | FARN | Faron 2024 Half-Year Financial Results | RNS |
| 27.08.2024 07:00 | FARN | FDA Grants Fast Track Designation for Bexmarilimab | RNS |
| 20.08.2024 14:21 | FARN, BNZL | UK earnings, trading statements calendar - next 7 days | Alliance |
| 20.08.2024 07:00 | FARN | Notice of Half-Year Financial Results | RNS |
| 13.08.2024 13:23 | FARN | IN BRIEF: Faron Pharmaceuticals joins US grant for battlefield wounds | Alliance |
| 13.08.2024 07:00 | FARN | Traumakine Research Collaboration and DoD Grant | Reach |
| 12.08.2024 12:01 | FLTR, IGG, SBRY | EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx | Alliance |
| 08.08.2024 07:00 | FARN | Appointment of Chief Financial Officer | RNS |
| 07.08.2024 10:00 | FARN | Grant of options | RNS |
| 06.08.2024 16:51 | FARN | IN BRIEF: Faron Pharmaceuticals names Petri Bono as CMO | Alliance |
| 06.08.2024 08:30 | FARN | Faron Appoints Dr. Petri Bono as new CMO | RNS |
